|1.||Gottesfeld, Joel M: 3 articles (01/2015 - 09/2012)|
|2.||Rusche, James R: 2 articles (01/2015 - 09/2012)|
|3.||Soragni, Elisabetta: 2 articles (01/2015 - 09/2012)|
|4.||Xu, Chunping: 2 articles (11/2014 - 09/2012)|
|5.||Kamal, Ahmed: 2 articles (10/2013 - 08/2012)|
|6.||Ramaiah, M Janaki: 2 articles (10/2013 - 08/2012)|
|7.||Pal-Bhadra, Manika: 2 articles (10/2013 - 08/2012)|
|8.||Tamboli, Jaki R: 2 articles (10/2013 - 08/2012)|
|9.||Zong, Xi: 1 article (01/2015)|
|10.||Sun, Chunlong: 1 article (01/2015)|
10/15/2013 - "It has previously been shown that anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates activate p53 and cause apoptosis in cervical cancer cells such as HeLa and SiHa. "
08/01/2012 - "A library of new anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates were designed, synthesized, and evaluated for their anticancer activity in cervical cancer cells such as HeLa and SiHa that possess low levels of p53. "
08/01/2012 - "Anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates as p53 activators in cervical cancer cells."
08/01/2007 - "SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer."
06/01/2006 - "New series histone deacetylase inhibitors comprising a hydroxamic acid or 2-aminobenzamide group as a zinc-chelating function were synthesized and evaluated for antiproliferative activities against a panel of human cancer cells. "
|2.||Friedreich Ataxia (Friedreich's Ataxia)
11/07/2014 - "Quantitative proteomic analysis identifies targets and pathways of a 2-aminobenzamide HDAC inhibitor in Friedreich's ataxia patient iPSC-derived neural stem cells."
01/01/2015 - "Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich's Ataxia."
09/01/2012 - "Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia."
11/07/2014 - "Members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics for the neurodegenerative diseases Friedreich's ataxia (FRDA) and Huntington's disease (HD). "
08/01/2013 - "A new series of anthranilamide derivatives were synthesized and evaluated for their antiproliferative activities against human colon carcinoma cell lines (HCT 116) and human breast adenocarcinoma cell lines (MDA-MB-231) in vitro. "
01/01/2013 - "Here, protein glycosylation of exosomes from ovarian carcinoma SKOV3 cells has been studied by lectin blotting, NP-HPLC analysis of 2-aminobenzamide labeled glycans and mass spectrometry. "
|4.||Neurodegenerative Diseases (Neurodegenerative Disease)
|5.||Interstitial Cystitis (Interstitial Cystitis, Chronic)
|1.||Histone Deacetylase Inhibitors
|5.||Protein Kinase Inhibitors
|6.||Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
|8.||Hydroxamic Acids (Hydroxamic Acid)
|9.||Histone Deacetylases (Histone Deacetylase)
|10.||DNA (Deoxyribonucleic Acid)